
Biotechnology
Idera Pharmaceuticals Inc. (NASDAQ:IDRA) is under investigation by Levi & Korsinsky, LLP, an established firm in securities litigation. What happened? Earlier in the day, it was announced that Idera Pharmaceuticals would be merging with BioCryst ... [Read]